“Metabolic reprogramming of tumor-associated macrophages using glutamine antagonist JHU083 drives tumor immunity in myeloid-rich prostate and bladder cancer tumors”的研究报告中,来自约翰霍普金斯大学医学院等机构的科学家们通过研究开发了一种新型疗法,其能重编程免疫细胞促进机体的抗肿瘤活性,从而帮助缩小小鼠机体...
Papers are stringently reviewed, and specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and...
近日,来自美国约翰霍普金斯大学医学院病理生物学的研究者们在Cancer Immunol Res杂志上发表了题为“Metabolic reprogramming of tumor-associated macrophages using glutamine antagonist JHU083 drives tumor immunity in myeloid-rich prostate and bladder cancer tumors”的文章,该研究表明JHU083靶向谷氨酰胺导致抑制肿瘤生长...
但并非所有患者都会对这种疗法产生反应,近日,一篇发表在国际杂志Cancer Immunology Research上题为“Combination IFNβ and membrane-stable CD40L maximize tumor dendritic cell activation and lymph node trafficking to elicit systemic T-cell immunity”的研究报告中,来自Moffitt癌症研究中心等机构的科学家们通过研究或有...
IMMUNITY 233 NEW ENGL J MED 223 SCIENCE 222 J EXP MED 220 P NATL ACAD SCI USA 210 相关期刊 亚洲外科杂志 Asian Journal Of Surgery 中科院分区 3区 JCR分区 Q1 查看详情 巴基斯坦医学杂志 Pakistan Journal Of Medical Sciences 中科院分区 4区 JCR分区 Q2 查看详情 癌症研究与临床肿瘤学杂志 Jour...
USP22immunitybladderMULTIPLE LEVELS OF PD-L1 REGULATION IN CANCER IMMUNOTHERAPY To date,the PD-1/PD-L1 blockade strategy has been tested in a variety of cancer types.However,only bladder cancer,melanoma,mismatch repair-deficient colorectal cancer,and certain hematopoietic malignancies have been highly ...
论文发表期刊《Frontiers in Immunology — Cancer Immunity and Immunotherapy》,最新影响因子为8.786,JCR分区:1区。论文第一作者是曹威医师,共同第一作者有周卫国医师和李梦莹医师。共同通讯作者还有熊茂明教授和曹国栋主治医师。图1 期刊信息...
2月1日,肿瘤免疫治疗学会(SITC,Society for Immunotherapy of Cancer)的官方杂志Journal for ImmunoTherapy of Cancer在线发表了田志刚课题组的最新研究成果”TIPE2 deletion improves the therapeutic potential of adoptively transferred NK cell...
文章3:一篇基础肿瘤免疫方面文章“Amino acids and RagD potentiate mTORC1 activation in CD8+T cells to confer antitumor immunity” 2021.3.17接收,2021.4.21发表。 文章4:一篇案例报道“Multiomics analysis reveals a distinct response mechanism in multiple primary lung adenocarcinoma after neoadjuvant immunothera...
2024年4月12日,陆军军医大学叶丽林团队与合作者中国农业大学张国中团队、北京大学白凡团队及南京大学李颜团队在Nature Cancer杂志发表了题为An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy的研究论文,该研究系统地阐明了TBYS细胞的...